Amy Kruse

Amy Kruse is a lead investor, scientific innovator, and business leader with a focus on improving human health span, well-being, and performance by collaborating with technologists, scientists, and entrepreneurs.

She holds a Ph.D. in Neuroscience, a B.S. in Cell and Structural Biology, and has studied Biomedical Engineering at reputable institutions like the University of Illinois Urbana-Champaign and Northwestern University.

With an extensive professional background, Amy has held various key positions in organizations such as Satori Capital, Prime Movers Lab, Cognixion, Gilgamesh Pharmaceuticals, and others, showcasing her expertise in strategic decision-making, investment management, and scientific leadership.

Her ability to identify commercially viable opportunities in neuroscience and biology, coupled with her skill in translating complex scientific concepts into marketable solutions, has distinguished her as a valuable asset in conceiving, leading, financing, and promoting successful projects and business units.

Amy Kruse's career spans across roles like General Partner, Chief Investment Officer, Venture Partner, Board Member, Strategic Advisor, Founder, President, and Chief Scientific Officer, highlighting her diverse experiences and contributions to various organizations in the field of science and technology.

She has also been involved in innovation councils, served on compensation committees, and held strategic advisory positions that further demonstrate her commitment to driving innovation, growth, and success in the companies and projects she is involved with.